---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-26-001110"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2026-08-14T19:43:42+00:00"
generated_at: "2026-08-14T19:45:11.361327+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lifeloc Q2 2026 revenue up 10% to $2.445M, net loss narrows to $(134K)

## Summary
- Q2 2026 net revenue $2.445M, up 10% YoY; net loss $(134K) or $(0.05) diluted vs $(394K) or $(0.14) in Q2 2025.
- Six-month revenue $4.739M, loss $(287K) or $(0.10) vs $4.496M and $(686K) or $(0.25) prior year.
- Gross margin improved to 45% from 42% YoY; R&D spend $560K on SpinDetect analyzer development.
- SpinDetect oral-fluid analyzer beta testing to start; limited commercial launch targeted for Q1 2027.
- Closed $500K loan from Chairman/CFO at 10.5% interest, secured by all assets, to fund operations.

## SEC filing metadata
- accession: 0001079973-26-001110
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2026-08-14T19:43:42+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997326001110/0001079973-26-001110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997326001110/lctc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-26-001110
- JSON: https://secwatch.observer/filing/0001079973-26-001110.json
- Plain text: https://secwatch.observer/filing/0001079973-26-001110.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.